Duk-woo Park, Md

This study tests whether a daily pill called enavogliflozin (a type of SGLT2 inhibitor) can reduce the risk of major heart problems or worsening heart failure in people who have already had a valve replacement for severe aortic stenosis and also have heart failure with preserved …

This study tests a new stomach acid-reducing drug (tegoprazan) against a standard one (rabeprazole) in about 3,320 heart patients who take blood thinners. The goal is to see if the new drug is as good at preventing serious stomach problems like bleeding and ulcers. Participants t…

This study compares two advanced heart procedures—stent placement (PCI) and bypass surgery (CABG)—in 1,500 people with diabetes and three blocked arteries. The goal is to see which approach better prevents death, heart attacks, or strokes. Participants are randomly assigned to on…

This study is a large registry that will follow 10,000 people who receive a TAVR procedure to replace a faulty heart valve. The goal is to see how well the procedure works over the long term in everyday medical practice. Researchers will track deaths, heart attacks, and other hea…